Check out Proactive Investors’ coverage of LexaGene’s contract with Alpine Veterinary Hospital – and Dr Regan’s upcoming conference appearances:
Proactive Investors on MiQLab Sale to Alpine Veterinary Hospital
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
September 14, 2022 - September 17, 2022
LexaGene will be exhibiting AAHA's Connexity Event in September.